MedTrace Logo

Continuous Glucose Monitoring in Hospitalized Patients With Diabetes Mellitus

NCT04653454 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 142

Last updated 2025-07-31

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if patient's own Continuous Glucose Monitor (CGMs) worn in the non-ICU hospital setting have adequate accuracy for blood glucose monitoring when compared to point-of-care (POC) capillary glucose measurement, and to determine if alerts given by CGMs worn in the non-ICU hospital would prevent episodes of hyperglycemia and hypoglycemia.

Conditions

Interventions

DEVICE

Continuous Glucose Monitor (CGM)

CGM data will be downloaded prior to discharge and it will be compared with hospital glucometer readings taken at the same time.

Sponsors & Collaborators

Principal Investigators

  • Adrian Dumitrascu, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2023-11-10
Completion
2023-11-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04653454 on ClinicalTrials.gov